The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Allen, R. M.
* Articles by Young, S. J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Allen, R. M.
* Articles by Young, S. J.

Am J Psychiatry 1978; 135:1081-1084
Copyright © 1978 by American Psychiatric Association


REGULAR ARTICLES

Phencyclidine-induced psychosis

RM Allen and SJ Young

During a 13-month period, 9 patients with phencyclidine-induced psychosis were admitted to Darnall Army Hospital. They exhibited hostility agitation, and tangentiality and had delusions of influence and religious grandiosity. Six subjects reported auditory hallucinations, and 4 were disoriented in at least 1 sphere. Despite treatment with antipsychotic medication, the psychotic episodes often persisted for more than 30 days. Our clinical finding of prolonged psychotic reactions, together with previous reports of the effects of phencyclidine, suggests that phenycyclidine provides an intriguing drug model for schizophrenia.


This article has been cited by other articles:


Home page
Schizophr BullHome page
A. Fornito, M. Yucel, B. Dean, S. J. Wood, and C. Pantelis
Anatomical Abnormalities of the Anterior Cingulate Cortex in Schizophrenia: Bridging the Gap Between Neuroimaging and Neuropathology
Schizophr Bull, April 23, 2008; (2008) sbn025v1.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
C. H. Large
Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
J Psychopharmacol, May 1, 2007; 21(3): 283 - 301.
[Abstract] [PDF]


Home page
Mol. Pharmacol.Home page
Z. Gu, Q. Jiang, and Z. Yan
RGS4 Modulates Serotonin Signaling in Prefrontal Cortex and Links to Serotonin Dysfunction in a Rat Model of Schizophrenia
Mol. Pharmacol., April 1, 2007; 71(4): 1030 - 1039.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
T. NABESHIMA, A. MOURI, R. MURAI, and Y. NODA
Animal Model of Schizophrenia: Dysfunction of NMDA Receptor-Signaling in Mice following Withdrawal from Repeated Administration of Phencyclidine
Ann. N.Y. Acad. Sci., November 1, 2006; 1086(1): 160 - 168.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
G. J. Paterson, Y. Ohashi, G. P. Reynolds, J. A. Pratt, and B. J. Morris
Selective increases in the cytokine, TNF{alpha}, in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects: influence of antipsychotic drugs
J Psychopharmacol, September 1, 2006; 20(5): 636 - 642.
[Abstract] [PDF]


Home page
Am. J. PsychiatryHome page
R. Narendran, W. G. Frankle, R. Keefe, R. Gil, D. Martinez, M. Slifstein, L. S. Kegeles, P. S. Talbot, Y. Huang, D.-R. Hwang, et al.
Altered Prefrontal Dopaminergic Function in Chronic Recreational Ketamine Users
Am J Psychiatry, December 1, 2005; 162(12): 2352 - 2359.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Enomoto, Y. Noda, A. Mouri, E.-J. Shin, D. Wang, R. Murai, K. Hotta, H. Furukawa, A. Nitta, H.-C. Kim, et al.
Long-Lasting Impairment of Associative Learning Is Correlated with a Dysfunction of N-Methyl-D-aspartate-Extracellular Signaling-Regulated Kinase Signaling in Mice after Withdrawal from Repeated Administration of Phencyclidine
Mol. Pharmacol., December 1, 2005; 68(6): 1765 - 1774.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
P. Svenningsson, G. G. Nomikos, and P. Greengard
Response to Comment on "Diverse Psychotomimetics Act Through a Common Signaling Pathway"
Science, July 9, 2004; 305(5681): 180d - 180d.
[Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
K. TOYOOKA, M. USUI, K. WASHIYAMA, T. KUMANISHI, and Y. TAKAHASHI
Gene Expression Profiles in the Brain from Phencyclidine-Treated Mouse by Using DNA Microarray
Ann. N.Y. Acad. Sci., June 1, 2002; 965(1): 10 - 20.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
N. TOMITA, M. MURATA, H. WATANABE, T. ICHIKAWA, K. WASHIYAMA, T. KUMANISHI, and Y. TAKAHASHI
The Effects of DCG-IV and L-CCG-1 upon Phencyclidine (PCP)-induced Locomotion and Behavioral Changes in Mice
Ann. N.Y. Acad. Sci., September 1, 2000; 914(1): 284 - 291.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
T. H. McGlashan and R. E. Hoffman
Schizophrenia as a Disorder of Developmentally Reduced Synaptic Connectivity
Arch Gen Psychiatry, July 1, 2000; 57(7): 637 - 648.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
V. P. Bakshi and M. A. Geyer
Phencyclidine-Induced Deficits in Prepulse Inhibition of Startle are Blocked by Prazosin, an Alpha-1 Noradrenergic Antagonist
J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 666 - 674.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
L. T. Thompson and J. F. Disterhoft
N-Methyl-D-Aspartate Receptors in Associative Eyeblink Conditioning: Both MK-801 and Phencyclidine Produce Task- and Dose-Dependent Impairments
J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 928 - 940.
[Abstract] [Full Text]


Home page
J PsychopharmacolHome page
P. H. Silverstone and D. G. Grahame-Smith
Smithkline Beecham Prize for Young Psychopharmacologists: A review of the relationship between calcium channels and psychiatric disorders
J Psychopharmacol, January 1, 1992; 6(4): 462 - 482.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1978 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org